ID   MZ2789RC
AC   CVCL_RV36
SY   MZ2789 RC
DR   Wikidata; Q54907255
RX   CelloPub=CLPUB00420;
RX   PubMed=12833523;
CC   Omics: Proteome analysis by 2D-DE/MS.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
RX   CelloPub=CLPUB00420;
RA   Bukur J.H.;
RT   "Characterization of T cell responses against human renal cell
RT   carcinoma and identification of HLA-G as a tumor-associated antigen
RT   and immune evasion mechanism of renal cell carcinoma.";
RL   Thesis PhD (2004); Johannes Gutenberg University Mainz; Mainz; Germany.
//
RX   PubMed=12833523; DOI=10.1002/pmic.200300404;
RA   Seliger B., Menig M., Lichtenfels R., Atkins D., Bukur J.H.,
RA   Halder T.M., Kersten M., Harder A., Ackermann A., Beck J.,
RA   Muehlenweg B., Brenner W., Melchior S., Kellner R., Lottspeich F.;
RT   "Identification of markers for the selection of patients undergoing
RT   renal cell carcinoma-specific immunotherapy.";
RL   Proteomics 3:979-990(2003).
//